ctrl K

Watchlist Price Alert

Galera Therapeutics Inc. (GRTX)

OTC: GRTX · Real-Time Price · USD

0.03

0.00 (9.09%)

At close: Apr 04, 2025, 2:24 PM

Galera Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	3.84M	259K	114K	778K	368K	267K	127K	84K
Gross Profit	-3.84M	-259K	-114K	-778K	-368K	-267K	-127K	-84K
Operating Income	-20.16M	-46.95M	-51.23M	-73.37M	-70.55M	-50.69M	-24.25M	-24.09M
Interest Income	554K	9.82M	506K	32K	1.17M	1.82M	606K	193K
Pretax Income	-19.16M	-59.08M	-62.29M	-80.53M	-74.23M	-51.94M	-23.9M	-23.91M
Net Income	-18.96M	-59.08M	-62.22M	-87.73M	-74.22M	-51.93M	-23.68M	-23.55M
Selling & General & Admin	11M	22.84M	20.21M	20.95M	15.71M	8.36M	5.59M	3.5M
Research & Development	3.15M	24.11M	31.01M	52.42M	54.84M	42.33M	18.66M	20.59M
Other Expenses	n/a	n/a	-11.07M	-7.17M	-3.68M	-1.25M	n/a	n/a
Operating Expenses	14.15M	46.69M	51.23M	73.37M	70.55M	50.69M	24.25M	24.09M
Interest Expense	n/a	n/a	11.57M	7.19M	4.88M	3.03M	220K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	18M	46.95M	51.23M	73.37M	70.55M	50.69M	24.25M	24.09M
Income Tax Expense	-203K	n/a	-70K	7.19M	-16K	-9K	-223K	-360K
Shares Outstanding (Basic)	54.63M	44.55M	27.09M	25.79M	24.87M	24.81M	19.36M	15.22M
Shares Outstanding (Diluted)	54.63M	44.55M	27.09M	25.79M	24.87M	24.81M	19.36M	15.22M
EPS (Basic)	-0.35	-1.33	-2.3	-3.4	-2.98	-2.09	-1.22	-1.55
EPS (Diluted)	-0.35	-1.33	-2.3	-3.4	-2.98	-2.09	-1.22	-1.55
EBITDA	-20.16M	-46.69M	-50.61M	-72.56M	-69.01M	-50.69M	-23.52M	-23.82M
EBIT	n/a	-70.5M	-50.72M	-73.34M	-69.35M	-48.91M	-23.68M	n/a
Depreciation & Amortization	n/a	259K	114K	778K	368K	267K	127K	84K